These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 26947770)

  • 21. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
    Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
    Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study.
    Melidonis A; Kamaratos A; Angelidi A; Thomakos P; Vrakas S; Bakalis J; Fousteris E; Iraklianou S
    Diabetes Technol Ther; 2016 Mar; 18(3):159-63. PubMed ID: 26862678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Continuous Glucose Monitoring on Hypoglycemia in Older Adults With Type 1 Diabetes: A Randomized Clinical Trial.
    Pratley RE; Kanapka LG; Rickels MR; Ahmann A; Aleppo G; Beck R; Bhargava A; Bode BW; Carlson A; Chaytor NS; Fox DS; Goland R; Hirsch IB; Kruger D; Kudva YC; Levy C; McGill JB; Peters A; Philipson L; Philis-Tsimikas A; Pop-Busui R; Shah VN; Thompson M; Vendrame F; Verdejo A; Weinstock RS; Young L; Miller KM;
    JAMA; 2020 Jun; 323(23):2397-2406. PubMed ID: 32543682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents.
    Holcombe JH; Zalani S; Arora VK; Mast CJ;
    Clin Ther; 2002 Apr; 24(4):629-38. PubMed ID: 12017407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ISPAD Guidelines. Managing diabetes in preschool children.
    Sundberg F; Barnard K; Cato A; de Beaufort C; DiMeglio LA; Dooley G; Hershey T; Hitchcock J; Jain V; Weissberg-Benchell J; Rami-Merhar B; Smart CE; Hanas R
    Pediatr Diabetes; 2017 Nov; 18(7):499-517. PubMed ID: 28726299
    [No Abstract]   [Full Text] [Related]  

  • 26. Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps.
    Melki V; Renard E; Lassmann-Vague V; Boivin S; Guerci B; Hanaire-Broutin H; Bringer J; Belicar P; Jeandidier N; Meyer L; Blin P; Augendre-Ferrante B; Tauber JP
    Diabetes Care; 1998 Jun; 21(6):977-82. PubMed ID: 9614617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with insulin glargine reduces asymptomatic hypoglycemia detected by continuous subcutaneous glucose monitoring in children and adolescents with type 1 diabetes.
    Deiss D; Kordonouri O; Hartmann R; Hopfenmüller W; Lüpke K; Danne T
    Pediatr Diabetes; 2007 Jun; 8(3):157-62. PubMed ID: 17550426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia.
    Sulli N; Shashaj B
    J Pediatr Endocrinol Metab; 2003 Mar; 16(3):393-9. PubMed ID: 12705364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes.
    Afandi B; Kaplan W; Al Hassani N; Hadi S; Mohamed A
    J Endocrinol Invest; 2017 Jul; 40(7):741-744. PubMed ID: 28239763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of MiniMed 640G with SmartGuard® System for prevention of hypoglycemia in pediatric patients with type 1 diabetes mellitus.
    Villafuerte Quispe B; Martín Frías M; Roldán Martín MB; Yelmo Valverde R; Álvarez Gómez MÁ; Barrio Castellanos R
    Endocrinol Diabetes Nutr; 2017 Apr; 64(4):198-203. PubMed ID: 28417874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Status and trends in the use of insulin analogs, insulin delivery systems and their association with glycemic control: comparison of the two consecutive recent cohorts of Japanese children and adolescents with type 1 diabetes mellitus.
    Yamamoto Y; Kikuchi T; Urakami T; Goto M; Tsubouchi K; Sasaki G; Mizuno H; Abe Y; Kitsuda K; Amemiya S; Sugihara S
    J Pediatr Endocrinol Metab; 2019 Jan; 32(1):1-9. PubMed ID: 30517078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rate of hypoglycaemia and insulin dosage in children during the initial therapy of type 1 diabetes mellitus.
    Herbst A; Roth CL; Dost AG; Fimmers R; Holl RW
    Eur J Pediatr; 2005 Oct; 164(10):633-8. PubMed ID: 16025296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of Dual-Hormone Closed-Loop Delivery System in the Future.
    Bally L; Thabit H; Hovorka R
    Diabetes Technol Ther; 2016 Aug; 18(8):452-4. PubMed ID: 27500812
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic control by insulin detemir in basal-bolus therapy: treat-to-target study in children and adolescents with type 1 diabetes.
    Nimri R; Lebenthal Y; Shalitin S; Benzaquen H; Demol S; Phillip M
    Pediatr Diabetes; 2013 May; 14(3):196-202. PubMed ID: 23289822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variations in the quality and sustainability of long-term glycaemic control with continuous subcutaneous insulin infusion.
    Nixon R; Folwell R; Pickup JC
    Diabet Med; 2014 Oct; 31(10):1174-7. PubMed ID: 24804864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
    Willi SM; Planton J; Egede L; Schwarz S
    J Pediatr; 2003 Dec; 143(6):796-801. PubMed ID: 14657831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of sensor augmented insulin pump therapy with low-glucose suspend feature in older adults: A retrospective study in Bogota, Colombia.
    Morros-González E; Gómez AM; Henao Carrillo DC; Ursida V; Serrano S; Rondón Sepúlveda MA; Muñoz Velandia OM
    Diabetes Metab Syndr; 2021; 15(3):649-653. PubMed ID: 33813236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control.
    Soliman AT; Omar M; Assem HM; Nasr IS; Rizk MM; El Matary W; El Alaily RK
    Metabolism; 2002 Mar; 51(3):292-6. PubMed ID: 11887162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.